BFM
SPPI

Boothbay Fund Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Boothbay Fund Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-228
Closed -$383K – 961
2018
Q3 		$383K Buy
+228
New +$4.93K 0.04% 440
2017
Q4 		– Sell
-374
Closed -$526K – 843
2017
Q3 		$526K Buy
+374
New +$3.38K 0.09% 251

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's SPPI Position: Q2 2023 in Review

Boothbay Fund Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2023, closing a stake of 30,401 shares — an estimated $22.8K sold.

Boothbay Fund Management first reported a position in SPPI in Q3 2016 and held it in 6 quarters. The position peaked at $58K in Q3 2016. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

  • Boothbay Fund Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 30,401 Spectrum Pharmaceuticals Inc shares in Q2 2023, an estimated $22.8K.
  • Boothbay Fund Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2016 and held it in 6 quarters.
  • Boothbay Fund Management's Spectrum Pharmaceuticals Inc position peaked at $58K in Q3 2016.
  • 78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.